Literature DB >> 10642437

CRIM1, a novel gene encoding a cysteine-rich repeat protein, is developmentally regulated and implicated in vertebrate CNS development and organogenesis.

G Kolle1, K Georgas, G P Holmes, M H Little, T Yamada.   

Abstract

Development of the vertebrate central nervous system is thought to be controlled by intricate cell-cell interactions and spatio-temporally regulated gene expressions. The details of these processes are still not fully understood. We have isolated a novel vertebrate gene, CRIM1/Crim1, in human and mouse. Human CRIM1 maps to chromosome 2p21 close to the Spastic Paraplegia 4 locus. Crim1 is expressed in the notochord, somites, floor plate, early motor neurons and interneuron subpopulations within the developing spinal cord. CRIM1 appears to be evolutionarily conserved and encodes a putative transmembrane protein containing an IGF-binding protein motif and multiple cysteine-rich repeats similar to those in the BMP-associating chordin and sog proteins. Our results suggest a role for CRIM1/Crim1 in CNS development possibly via growth factor binding.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10642437     DOI: 10.1016/s0925-4773(99)00248-8

Source DB:  PubMed          Journal:  Mech Dev        ISSN: 0925-4773            Impact factor:   1.882


  31 in total

Review 1.  The establishment of Spemann's organizer and patterning of the vertebrate embryo.

Authors:  E M De Robertis; J Larraín; M Oelgeschläger; O Wessely
Journal:  Nat Rev Genet       Date:  2000-12       Impact factor: 53.242

2.  Unraveling the molecular targets pertinent to junction restructuring events during spermatogenesis using the Adjudin-induced germ cell depletion model.

Authors:  Weiliang Xia; Dolores D Mruk; Will M Lee; C Yan Cheng
Journal:  J Endocrinol       Date:  2007-03       Impact factor: 4.286

3.  Crimpy inhibits the BMP homolog Gbb in motoneurons to enable proper growth control at the Drosophila neuromuscular junction.

Authors:  Rebecca E James; Heather T Broihier
Journal:  Development       Date:  2011-08       Impact factor: 6.868

4.  Crimpy enables discrimination of presynaptic and postsynaptic pools of a BMP at the Drosophila neuromuscular junction.

Authors:  Rebecca E James; Kendall M Hoover; Dinara Bulgari; Colleen N McLaughlin; Christopher G Wilson; Kristi A Wharton; Edwin S Levitan; Heather T Broihier
Journal:  Dev Cell       Date:  2014-11-20       Impact factor: 12.270

5.  CRIM1 haploinsufficiency causes defects in eye development in human and mouse.

Authors:  Filippo Beleggia; Yun Li; Jieqing Fan; Nursel H Elcioğlu; Ebru Toker; Thomas Wieland; Irene H Maumenee; Nurten A Akarsu; Thomas Meitinger; Tim M Strom; Richard Lang; Bernd Wollnik
Journal:  Hum Mol Genet       Date:  2015-01-05       Impact factor: 6.150

6.  Cellular and molecular responses of the uterus to embryo implantation can be elicited by locally applied growth factors.

Authors:  B C Paria; W Ma; J Tan; S Raja; S K Das; S K Dey; B L Hogan
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

Review 7.  Neural induction and early patterning in vertebrates.

Authors:  Mohammad Zeeshan Ozair; Chris Kintner; Ali H Brivanlou
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2012-10-15       Impact factor: 5.814

8.  Crim1C140S mutant mice reveal the importance of cysteine 140 in the internal region 1 of CRIM1 for its physiological functions.

Authors:  Tatsuya Furuichi; Manami Tsukamoto; Masaki Saito; Yuriko Sato; Nobuyasu Oiji; Kazuhiro Yagami; Ryutaro Fukumura; Yoichi Gondo; Long Guo; Shiro Ikegawa; Yu Yamamori; Kentaro Tomii
Journal:  Mamm Genome       Date:  2019-11-27       Impact factor: 2.957

Review 9.  Agonists and Antagonists of TGF-β Family Ligands.

Authors:  Chenbei Chang
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-08-01       Impact factor: 10.005

10.  The pro-BMP activity of Twisted gastrulation is independent of BMP binding.

Authors:  Michael Oelgeschläger; Bruno Reversade; Juan Larraín; Shawn Little; Mary C Mullins; E M De Robertis
Journal:  Development       Date:  2003-09       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.